OR7E55P

Across TCGA pan-cancer cohorts, OR7E55P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR7E55P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where OR7E55P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E55P is over-expressed in tumor.

LIHC are the cancer types where OR7E55P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E55P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	III,IV	+0.037	.025	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

OR7E55P–LIHC

Open the LIHC breakdown →